Browse All

Current Filters

CLEAR FILTER x

TITLE

Basimglurant, a Novel mGluR5 Negative Allosteric Modulator, is Analgesic in Animal Models of Neuropathic and Chronic Pain

LIBRA Study: Design of an enriched randomized withdrawal, placebo-controlled, Phase 2/3 trial of basimglurant, a first-in-class mGluR5 NAM, to treat pain associated with Trigeminal Neuralgia